ClinicalTrials.Veeva

Menu

Molecular Characterization of Induced Neuronal Cells in Parkinson's Disease

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Procedure: Skin biopsy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To describe the molecular, electrophysiological and morphological expression profile of dopaminergic neurons derived from fibroblasts of patients with Parkinson's disease.

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects aged 18 years or older
  2. Patients with Parkinson's disease, according to the most recent diagnostic criteria
  3. Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study

Exclusion criteria

  1. Patients affected by drug-induced parkinsonism or atypical parkinsonian disorders
  2. Patients with neurological diseases other than Parkinson's disease
  3. Inability to sign an informed consent
  4. Severe psychiatric diseases

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

45 participants in 1 patient group

Skin biopsy
Experimental group
Treatment:
Procedure: Skin biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Flavia Torlizzi; Guido Alessandro Primiano, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems